Viewing StudyNCT00263822



Ignite Creation Date: 2024-05-05 @ 12:10 PM
Last Modification Date: 2024-10-26 @ 9:21 AM
Study NCT ID: NCT00263822
Status: COMPLETED
Last Update Posted: 2013-08-27
First Post: 2005-12-07

Brief Title: Erlotinib or Observation in Treating Patients Who Have Undergone First-Line Chemotherapy for Ovarian Cancer Peritoneal Cancer or Fallopian Tube Cancer
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Organization: European Organisation for Research and Treatment of Cancer - EORTC

Conditions & Keywords Data

Conditions:
Name
Primary Peritoneal Cavity Cancer
Fallopian Tube Cancer
Ovarian Cancer
Keywords:
Name View
fallopian tube cancer View
stage I ovarian epithelial cancer View
stage II ovarian epithelial cancer View
stage III ovarian epithelial cancer View
stage IV ovarian epithelial cancer View
primary peritoneal cavity cancer View